BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1246 related articles for article (PubMed ID: 26755860)

  • 1. Metabolic derivatives of alcohol and the molecular culprits of fibro-hepatocarcinogenesis: Allies or enemies?
    Boye A; Zou YH; Yang Y
    World J Gastroenterol; 2016 Jan; 22(1):50-71. PubMed ID: 26755860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of alcoholic liver disease: role of oxidative metabolism.
    Ceni E; Mello T; Galli A
    World J Gastroenterol; 2014 Dec; 20(47):17756-72. PubMed ID: 25548474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carcinogenic Etheno DNA Adducts in Alcoholic Liver Disease: Correlation with Cytochrome P-4502E1 and Fibrosis.
    Mueller S; Peccerella T; Qin H; Glassen K; Waldherr R; Flechtenmacher C; Straub BK; Millonig G; Stickel F; Bruckner T; Bartsch H; Seitz HK
    Alcohol Clin Exp Res; 2018 Feb; 42(2):252-259. PubMed ID: 29120493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alcohol, microbiome, life style influence alcohol and non-alcoholic organ damage.
    Neuman MG; French SW; Zakhari S; Malnick S; Seitz HK; Cohen LB; Salaspuro M; Voinea-Griffin A; Barasch A; Kirpich IA; Thomes PG; Schrum LW; Donohue TM; Kharbanda KK; Cruz M; Opris M
    Exp Mol Pathol; 2017 Feb; 102(1):162-180. PubMed ID: 28077318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linker phosphorylation of Smad3 promotes fibro-carcinogenesis in chronic viral hepatitis of hepatocellular carcinoma.
    Murata M; Yoshida K; Yamaguchi T; Matsuzaki K
    World J Gastroenterol; 2014 Nov; 20(41):15018-27. PubMed ID: 25386050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of alcohol in liver carcinogenesis.
    McKillop IH; Schrum LW
    Semin Liver Dis; 2009 May; 29(2):222-32. PubMed ID: 19387921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acetaldehyde adducts in alcoholic liver disease.
    Setshedi M; Wands JR; Monte SM
    Oxid Med Cell Longev; 2010; 3(3):178-85. PubMed ID: 20716942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-17 signaling in steatotic hepatocytes and macrophages promotes hepatocellular carcinoma in alcohol-related liver disease.
    Ma HY; Yamamoto G; Xu J; Liu X; Karin D; Kim JY; Alexandrov LB; Koyama Y; Nishio T; Benner C; Heinz S; Rosenthal SB; Liang S; Sun M; Karin G; Zhao P; Brodt P; Mckillop IH; Quehenberger O; Dennis E; Saltiel A; Tsukamoto H; Gao B; Karin M; Brenner DA; Kisseleva T
    J Hepatol; 2020 May; 72(5):946-959. PubMed ID: 31899206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progression of alcoholic and non-alcoholic steatohepatitis: common metabolic aspects of innate immune system and oxidative stress.
    Sakaguchi S; Takahashi S; Sasaki T; Kumagai T; Nagata K
    Drug Metab Pharmacokinet; 2011; 26(1):30-46. PubMed ID: 21150132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs in alcoholic liver disease.
    Szabo G; Satishchandran A
    Semin Liver Dis; 2015 Feb; 35(1):36-42. PubMed ID: 25632933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors and mechanisms of hepatocarcinogenesis with special emphasis on alcohol and oxidative stress.
    Seitz HK; Stickel F
    Biol Chem; 2006 Apr; 387(4):349-60. PubMed ID: 16606331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiological Aspects of Alcohol Metabolism in the Liver.
    Hyun J; Han J; Lee C; Yoon M; Jung Y
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbiome-Based Metabolic Therapeutic Approaches in Alcoholic Liver Disease.
    Hyun JY; Kim SK; Yoon SJ; Lee SB; Jeong JJ; Gupta H; Sharma SP; Oh KK; Won SM; Kwon GH; Cha MG; Kim DJ; Ganesan R; Suk KT
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alcohol-associated liver disease.
    Mackowiak B; Fu Y; Maccioni L; Gao B
    J Clin Invest; 2024 Feb; 134(3):. PubMed ID: 38299591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus and alcohol: same mitotic targets but different signaling pathways.
    Alisi A; Ghidinelli M; Zerbini A; Missale G; Balsano C
    J Hepatol; 2011 May; 54(5):956-63. PubMed ID: 21145809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic non-parenchymal cells: Master regulators of alcoholic liver disease?
    Seo W; Jeong WI
    World J Gastroenterol; 2016 Jan; 22(4):1348-56. PubMed ID: 26819504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Alcoholic liver diseases in Japan and modification by hepatitis virus].
    Horie Y; Yamagishi Y; Ishii H
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2003 Oct; 38(5):403-14. PubMed ID: 14639919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Key Signaling in Alcohol-Associated Liver Disease: The Role of Bile Acids.
    Way GW; Jackson KG; Muscu SR; Zhou H
    Cells; 2022 Apr; 11(8):. PubMed ID: 35456053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alcoholic liver disease and the potential role of plasminogen activator inhibitor-1 and fibrin metabolism.
    Beier JI; Arteel GE
    Exp Biol Med (Maywood); 2012 Jan; 237(1):1-9. PubMed ID: 22238286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Alcoholic liver disease].
    Waluga M; Hartleb M
    Wiad Lek; 2003; 56(1-2):61-70. PubMed ID: 12901271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 63.